Metraipolis › archive › dc_cd779f8e765b
Next-Generation Nanocarrier Platforms for RNA Vaccines: Advances in Formulation, Stability Engineering, and Translational Manufacturing Challenges — Europe PMC PMID:42654026
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42654026
- DOI
- 10.3390/pharmaceutics18080909
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T22:06:31.582Z
- SHA-256 of the archived text
056316a9b67f1905b726d882e83f3929918cb02604968edaf6d726a0e3701fec- Stable URL of this page
https://metraipolis.com/documento/dc_cd779f8e765b
How to cite
Next-Generation Nanocarrier Platforms for RNA Vaccines: Advances in Formulation, Stability Engineering, and Translational Manufacturing Challenges — Europe PMC PMID:42654026 — Europe PMC (en), https://europepmc.org/article/MED/42654026 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd779f8e765b (Metraipolis archive dc_cd779f8e765b, sha256 056316a9b67f1905b726d882e83f3929918cb02604968edaf6d726a0e3701fec)
BibTeX
@misc{dccd779f8e765b,
title = {Next-Generation Nanocarrier Platforms for RNA Vaccines: Advances in Formulation, Stability Engineering, and Translational Manufacturing Challenges — Europe PMC PMID:42654026},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42654026},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd779f8e765b; sha256 056316a9b67f1905b726d882e83f3929918cb02604968edaf6d726a0e3701fec},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42654026. Agents can read the archived copy with the MCP tool read_document.